D. King

发表

The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development

J. Macor, M. Weed, L. Bristow, 2016, PloS one.

Synthesis and release of doxorubicin from a cephalosporin based prodrug by a β-lactamase-immunoconjugate

K. Bush, R. Firestone, K. Colson, 1993 .

BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder.

J. Macor, A. Mathur, B. Srikumar, 2018, ACS medicinal chemistry letters.

Synthesis of water-soluble prodrugs of BMS-191011: a maxi-K channel opener targeted for post-stroke neuroprotection.

Astrid A. Ortiz, V. Gribkoff, J. Knipe, 2003, Bioorganic & medicinal chemistry letters.

Enantioselective Synthesis of a Highly Potent Selective Serotonin Reuptake Inhibitor. An Application of Imidazolidinone Catalysis to the Alkylation of Indoles with an α,β-Disubstituted α,β-Unsaturated Aldehyde

J. Macor, R. Mattson, Qi Gao, 2005 .

Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitors.

J. Macor, Shuang Liu, T. Molski, 2014, ACS medicinal chemistry letters.

Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains

R. Cardinal, J. Macor, M. Weed, 2016, Neuropsychopharmacology.

Facile synthesis of maleimide bifunctional linkers

G. Dubowchik, M. A. Walker, D. King, 2002 .

Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SAR.

M. D. Hill, J. Macor, Yulia Benitex, 2017, Bioorganic & medicinal chemistry letters.

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.

J. Macor, Yulia Benitex, D. Post‐Munson, 2017, ACS medicinal chemistry letters.

The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia

J. Macor, Yulia Benitex, D. Post‐Munson, 2016, PloS one.

Efficient mitomycin C coupling with stable p-nitrophenyl-benzyl carbonates using n-hydroxybenzotriazole as a catalytic additive

G. Dubowchik, D. King, K. Pham-Kaplita, 1997 .

NMDA Antagonists of GluN2B Subtype and Modulators of GluN2A, GluN2C, and GluN2D Subtypes—Recent Results and Developments

R. Olson, D. King, Kamalesh B. P. Ruppa, 2012 .

Nicotinic alpha 7 receptor agonists EVP-6124 and BMS-933043, attenuate scopolamine-induced deficits in visuo-spatial paired associates learning

J. Macor, Yulia Benitex, R. Olson, 2017, PloS one.

Monoclonal antibody drug immunoconjugates for targeted treatment of cancer

P. Trail, G. Dubowchik, D. King, 2003, Cancer Immunology, Immunotherapy.

Conformationally restricted homotryptamines. Part 7: 3-cis-(3-aminocyclopentyl)indoles as potent selective serotonin reuptake inhibitors.

B. Beno, J. Macor, T. Molski, 2010, Journal of medicinal chemistry.

Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains.

P. Trail, H. D. King, G. Dubowchik, 2002, Journal of medicinal chemistry.

Monoclonal antibody mediated intracellular targeting of tallysomycin S(10b).

P. Trail, R. Dalterio, H. D. King, 2004, Bioorganic & medicinal chemistry letters.

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.

J. Macor, Yulia Benitex, D. Post‐Munson, 2017, ACS medicinal chemistry letters.

Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder

J. Macor, A. Mathur, B. Srikumar, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.

P. Trail, T. Doyle, I. Hellstrom, 1997, Cancer research.